Expression of a nonclassical MHC class Ib molecule in the eye

Transplantation

Volumn 68, Issue 11, 1999, Pages 1790-1799

  Niederkorn, Jerry Y ^a   Chiang, Eugene Y ^a   Ungchusri, Threedanuj ^a   Stroynowski, Iwona ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTERIOR EYE CHAMBER; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; GRAFT REJECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033572884     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199912150-00025     Document Type: Article

References (58)

1. Flaherty L, Elliott E, Tine JA, Walsh AC. Immunogenetics of the Q and TL regions of the mouse. Crit Rev Immunol 1990; 10: 131.
2. Shavar SM, Vyas JM, Rodgers JR, Rich RR. Antigen presentation by major histocompatibility complex class Ib molecules. Annu Rev Immunol 1994; 12: 839.
3. Stroynowski I, Fischer Lindahl K. Antigen presentation by non-classical class I molecules. Curr Opin Immunol 1994; 6: 38.
4. Pamer, EG, Wang CR, Flaherty L, Fisher Lindahl K, Bevan MJ. H-2 M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell 1992; 70: 215.
5. - T lymphocytes to a microbial antigen. Nature 1992; 360: 593.
6. Schofield L, McConville MJ, Hansen D, et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999; 283: 225.
7. Stroynowski I, Tabaczewski P. Multiple products of class Ib Qa-2 genes: which ones are functional? Res Immunol 1996; 147: 290.
8. Griffiths E, Ong H, Soloski MJ, Bachmann MF, Ohashi PS, Speiser DE. Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I. Cancer Res 1998; 58: 4682.
9. Braud VM, Allan DSJ, O'Callaghan CA, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795.
10. b. J Exp Med 1998; 188: 1841.
11. Colonna M, Navarro F, Bellon T, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997; 186: 1809.
12. LeBouteiller P. HLA class I chromosomal region, genes, and products: facts and questions. Crit Rev Immunol 1994; 14: 89.
13. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 1992; 89: 3947.
14. Ulker N, Lewis KD, Hood LE, Stroynowski I. Activated T cells transcribe an alternatively spliced mRNA encoding a soluble form of Qa-2 antigen. EMBO J 1990; 9: 3839.
15. Lee N, Malacko AR, Ishitani A, et al. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995; 3: 91.
16. Joyce S, Tabaczewski P, Angeletti R, Nathenson S, Stroynowski I. A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides. J Exp Med 1994; 179: 579.
17. Tabaczewski P, Chiang E, Henson M, Stroynowski I. Alternative peptide binding motifs of Qa-2 class Ib molecules define rules for binding of self and nonself peptides. J Immunol 1997; 159: 2771.
18. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, Demars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 20.
19. Harris RA, Hogarth PM, Penington DG, McKenzie IFC. Qa antigens and their differential distribution on lymphoid, myeloid and stem cells. J Immunogenet 1984; 11: 265.
20. Yue BY, Sugar J, Gilboy JE, Elvart JL. Growth of human corneal endothelial cells in culture. Invest Ophthalmol Vis Sci 1989; 30: 248.
21. He Y-G, McCulley JP. Growing human corneal epithelium on collagen shield and subsequent transfer to denuded cornea in vitro. Curr Eye Res 1991; 10: 851.
22. Wilson SW, Weng J, Blair S, He Y-G, Lloyd S. Expression of E6/E7 or SV40 large antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci 1995; 36: 32.
23. Streilein JW, Bradley D. Analysis of immunosuppressive properties of iris and ciliary body and their secretory products. Invest Ophthalmol Vis Sci 1991; 32: 2700.
24. Hasenkrug KJ, Cory JM, Stimpfling JH. Monoclonal antibodies defining mouse tissue antigens encoded by the H-2 region. Immunogenetics 1987; 25: 136.
25. Sharrow SO, Flaherty L, Sachs DH. Serologic cross-reactivity between class I MHC molecules and H-2-linked differentiation antigen as detected by monoclonal antibodies. J Exp Med 1984; 159: 21.
26. Tabaczewski P, Shirwan H, Lewis K, Stroynowski I. Alternative splicing of class Ib major histocompatibility complex transcripts in vivo leads to the expression of soluble Qa-2 molecules in murine blood. Proc Natl Acad Sci USA 1994; 91: 1883.
27. Jones B, Janeway CA. Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature 1981; 292: 547.
28. d antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J Immunol 1980; 125: 2473.
29. Oi VT, Jones PP, Coding JW, Herzenberg LA, Herzenberg LA. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr Top Microbiol Immunol 1978; 81: 115.
30. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd Edition. New York: Cold Spring Harbor Laboratory Press, 1989.
31. Cai W, Cao W, Wu L, et al. Sequence and transcription of Qa-2-encoding genes in mouse lymphocytes and blastocysts. Immunogenetics 1996; 45: 97.
32. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S. Nucleotide sequence of a full length cDNA for mouse cytoskeletal β-actin mRNA. Nucleic Acids Res 1986; 14: 2829.
33. Tabaczewski P, Stroynowski I. Expression of secreted and glycosylphosphatidylinositol-bound Qa-2 molecules is dependent on functional TAP-2 peptide transporter. J Immunol 1994; 152: 5268.
34. Fahrner K, Hogan BLM, Flavell RA. Transcription of H-2 and Qa genes in embryonic and adult mice. EMBO J 1987; 6: 1265.
35. Wang Q, Flaherty L. Developmental expression of the mouse MHC Q genes. Eur J Immunogenetics 1996; 23: 121.
36. Paus R, Eichmuller S, Hofmann V, Czarnetzki BM, Robinson P. Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol 1994; 131: 177.
37. Lolley RN, Farber DB. Abnormal guanosine 3′,5′-monophosphate during photoreceptor degeneration in the inherited retinal disorder of C3H/HeJ mice. Ann Ophthalmol 1976; 8: 469.
38. Streilein JW. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye. Eye 1995; 9: 236.
39. Streilein JW. Unraveling immune privilege. Science 1995; 270: 1158.
40. Ferguson TA, Griffith TS. A vision of cell death: insights into immune privilege. Immunol Rev 1997; 156: 167.
41. Fujikawa LS, Colvin RB, Bhan AK, Fuller TC, Foster CS. Expression of HLA-A/B/C and DR locus antigens on epithelial, stromal, and endothelial cells of the human cornea. Cornea 1982; 1: 213.
42. Meyer D, Daar A, Casey T, Fabre J. Localization of HLA-A, B, C and HLA-DR antigens in the human cornea: practical significance for grafting technique and HLA typing. Transplant Proc 1983; 14: 126.
43. Treseler P, Foulks G, Sanfilippo F. The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol 1984; 98: 763.
44. Pepose J, Gardner K, Nestor M, Foos R, Pettit T. Detection of HLA class I and II antigens in rejected human corneal allografts. Ophthalmology 1985; 92: 1480.
45. Lynch M, Peeler J, Brown R, Niederkorn J. Expression of HLA class I and II antigens on cells of human trabecular meshwork. Ophthalmology 1986; 94: 851.
46. Bakker M, Grumet FC, Feltkamp TEW, Kijlstra A. HLA-antigens in the human uvea. Doc Ophthalmol 1986; 61: 271.
47. Wang HM, Kaplan HJ, Chan WC, Johnson M. The distribution and ontogeny of MHC antigens in murine ocular tissue. Invest Ophthalmol Vis Sci 1987; 28: 1383.
48. Abi-Hanna D, Wakefield D, Watkins S. HLA antigens in ocular tissues. I. In vivo expression in human eyes. Transplantation 1988; 45: 610.
49. Tripathi BJ, Tripathi RC, Wong P, Raja S. Expression of HLA by the human trabecular meshwork and corneal endothelium. Exp Eye Res 1990; 51: 269.
50. Fragoso G, Lamoyi E, Mellor A, Lomeli C, Hernandez M, Sciutto D. Increased resistance to Taenia crassiceps murine cysticercosis in Qa-2 transgenic mice. Infect Immun 1998; 66: 760.
51. Apte RS, Niederkorn JY. Isolation of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol 1996; 156: 2667.
52. Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY. Role of macrophage migration factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 1998; 160: 5693.
53. Shukla H, Swaroop A, Srivastava R, Weissman SM. The mRNA of a human class I gene HLA G/HLA 6.0 exhibits a restricted pattern of expression. Nucleic Acids Res 1990; 18: 2189.
54. Chumbley G, King A, Gardner L, Howlett S, Holmes N, Loke YW. Generation of an antibody to HLA-G in transgenic mice and demonstration of the tissue reactivity of this antibody. J Reprod Immunol 1994; 27: 173.
55. Haskova Z. Filipec M, Holan V. The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice. Folia Biologica 1996; 42: 105.
56. Sano Y, Ksander BR, Streilein JW. Murine orthotopic corneal transplantation in high-risk eyes: rejection is dictated primarily by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci 1997; 38: 1130.
57. Hendricks RL, Tumpey TM. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology. Invest Ophthalmol Vis Sci 1990; 31: 1929.
58. Knisely TL, Niederkorn JY. Immunologic evaluation of spontaneous regression of an intraocular murine melanoma. Invest Ophthalmol Vis Sci 1990; 31: 247.